TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

As of Apr 2

BusinessUnited States1 sourcesNeutral

INOVIO Announces Proposed Public Offering

PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced...

CP

cision pr newswire

via Pr Newswire

April 2, 2026 | 12:05 AM UTCUpdated 2h ago

Share Read original

Read the full article at Pr Newswire →

INOVIO Announces Proposed Public Offering

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments

Be respectful and constructive.

Loading comments...

Artemis II, NASA's boldest mission in generations, launches crew to the Moon

Could what you have actually be endometriosis?

Related Articles

Tanfield Reports Wider FY'25 Loss; Revenue Remains Nil

Unknown-2h ago-1 sources

Texas Opens Applications For $350M Advanced Nuclear Fund

Texas Opens Applications For $350M Advanced Nuclear Fund

Hoodline-14h ago-1 sources

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2026

Biospace-14h ago-1 sources